Close Menu

NEW YORK – Transplant diagnostics firm CareDx reported after the close of the market on Thursday that its fourth quarter revenues rose 52 percent year over year, largely thanks to a 54 percent increase in testing revenues.

For the three months ended Dec. 31, 2019, the company reported total revenues of $35.8 million, up from $23.5 million in the fourth quarter of 2018, and in line with the Wall Street estimate.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.